|
Content :
Supporting change
Background and Sanofi’s commitment
Since 2009, Sanofi has implemented a wide-ranging transformation program to become a diversified global healthcare company focused on patient needs. All Group entities have been involved in this transformation process: Research & Development, Industrial Affairs, Commercial Operations, Vaccines and the support functions. The Group must adapt and progress to remain competitive internationally. We are migrating research and industrial facilities toward biotechnologies. We are also adjusting our sales forces in response to growing regulatory constraints (e.g. drugs being excluded from reimbursement or subject to price regulation) and generic competition for some of the Group’s flagship products. In certain regions of the globe, and particularly in emerging markets, we must strengthen Sanofi’s presence in response to countries’ development and their populations’ access to care. In each country, employee representative bodies and employees are regularly informed about the Group’s strategy and the need for organizational transformations to meet the challenge of an increasingly competitive environment. Based on transparency, negotiations take place to implement necessary and appropriate support measures while taking into account local regulations. Our transformation program has been implemented progressively in all affected countries, and Sanofi is committed to supporting impacted employees as they change functions or organizations. The challenge facing the Group is to offer each employee a solution adapted to his or her needs. This requires anticipating change (training needs, site conversions, investments, etc.) and negotiating with employee representative organizations about support measures, where appropriate. It also entails keeping employees informed and taking the time required to fine-tune adjustments. Two types of actions are essential to supporting change: - Assisting employees during the Group’s transformation
- Strengthening and integrating teams in areas with high growth potential, in particular following the acquisition of Genzyme and Merial
"Sanofi’s socially responsible approach entails anticipation and the ability to react quickly, including being able to adapt to technological developments and broader change."
Excerpt from the Sanofi Social Charter "Sanofi aims to combine economic and social performance and recognizes these are inseparable."
Excerpt from the Sanofi Social Charter While strengthening our high expertise in the traditional chemistry, we are moving towards biotechnologies and building synergies with vaccines. Francis Carré,
Industrial Affairs Chemistry and Biotechnology |
